High remnant cholesterol as a risk factor for developing chronic kidney disease in patients with prediabetes and type 2 diabetes: a cross-sectional study of a US population

被引:0
作者
Wenting Zhu
Qiushi Liu
Fang Liu
Chenfeng Jiao
Lihua Zhang
Honglang Xie
机构
[1] Nanjing Medical Univerisity,National Clinical Research Center of Kidney Diseases, Jinling Hospital
[2] The First Affiliated Hospital of Anhui Medical University,The Department of Urology
[3] Anhui Medical University,Institute of Urology and Anhui Province Key Laboratory of Genitourinary Diseases
来源
Acta Diabetologica | 2024年 / 61卷
关键词
Remnant cholesterol; Prediabetes; Type 2 diabetes mellitus; Chronic kidney disease; NHANES;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:735 / 743
页数:8
相关论文
共 144 条
[1]  
Coresh J(2007)Prevalence of chronic kidney disease in the United States JAMA 298 2038-2047
[2]  
Selvin E(2013)Chronic kidney disease: global dimension and perspectives Lancet 382 260-272
[3]  
Stevens LA(2016)Association between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis Diabet Med 33 1615-1624
[4]  
Jha V(2003)Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study Diabetes Care 26 2604-2608
[5]  
Garcia-Garcia G(2004)Isolate diffuse thickening of glomerular capillary basement membrane: a renal lesion in prediabetes? Mod Pathol 17 1506-1512
[6]  
Iseki K(2016)Prediabetes as a precursor to diabetic kidney disease Am J Kidney Dis 67 817-819
[7]  
Echouffo-Tcheugui J(2008)Economic burden of chronic kidney disease J Eval Clin Pract 14 422-434
[8]  
Narayan K(2022)Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes Diabetes Res Clin Pract 190 886-899
[9]  
Weisman D(2015)Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia 58 1918-1925
[10]  
Golden SH(2004)Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype Circulation 109 2712-2724